Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ASTS, PL, RVMD, ARM, FRSH, and represent 75.93% of Alphabet's stock portfolio.
- Reduced shares in these 10 stocks: MTSR (-$198M), RVMD (-$63M), MAZE (-$42M), GLUE (-$11M), DNTH (-$8.2M), FHTX, TSHA, TCRX, BRNS, GUTS.
- Sold out of its positions in ALEC, DNTH, FHTX, GUTS, MTSR, TSHA, TCRX, BRNS.
- Alphabet was a net seller of stock by $-333M.
- Alphabet has $2.6B in assets under management (AUM), dropping by 7.11%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Alphabet
Alphabet holds 29 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ast Spacemobile Com Cl A (ASTS) | 25.2 | $650M | 8.9M | 72.63 |
|
|
| Planet Labs Pbc Com Cl A (PL) | 24.4 | $630M | 32M | 19.72 |
|
|
| Revolution Medicines (RVMD) | 10.3 | $266M | -19% | 3.3M | 79.65 |
|
| Arm Holdings Sponsored Ads (ARM) | 8.3 | $214M | 2.0M | 109.31 |
|
|
| Freshworks Class A Com (FRSH) | 7.7 | $199M | 16M | 12.25 |
|
|
| Uipath Cl A (PATH) | 4.5 | $115M | 7.0M | 16.39 |
|
|
| Gitlab Class A Com (GTLB) | 4.0 | $102M | 2.7M | 37.53 |
|
|
| Tempus Ai Cl A (TEM) | 3.6 | $92M | 1.6M | 59.05 |
|
|
| Dex (DXCM) | 2.7 | $69M | 1.0M | 66.37 |
|
|
| Maze Therapeatics (MAZE) | 2.2 | $58M | -42% | 1.4M | 41.43 |
|
| Prime Medicine (PRME) | 2.2 | $58M | 17M | 3.47 |
|
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 1.4 | $35M | 2.8M | 12.52 |
|
|
| Relay Therapeutics (RLAY) | 0.5 | $13M | 1.6M | 8.46 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.5 | $12M | 241k | 50.64 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.5 | $12M | -49% | 745k | 15.68 |
|
| Sana Biotechnology (SANA) | 0.4 | $11M | 2.8M | 4.07 |
|
|
| Lyell Immunopharma Com New (LYEL) | 0.3 | $9.0M | 293k | 30.78 |
|
|
| Beam Therapeutics (BEAM) | 0.3 | $8.9M | 322k | 27.72 |
|
|
| Figma Class A Com Stk (FIG) | 0.3 | $8.1M | 216k | 37.37 |
|
|
| Oscar Health Cl A (OSCR) | 0.3 | $6.9M | 482k | 14.37 |
|
|
| Genedx Holdings Corp (WGS) | 0.1 | $3.0M | 23k | 130.06 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $2.4M | 23k | 101.56 |
|
|
| Spero Therapeutics (SPRO) | 0.1 | $2.1M | 890k | 2.33 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $1.4M | 698k | 1.99 |
|
|
| Hyperfine Com Cl A (HYPR) | 0.0 | $881k | 899k | 0.98 |
|
|
| Tenaya Therapeutics (TNYA) | 0.0 | $650k | 916k | 0.71 |
|
|
| Cortexyme (QNCX) | 0.0 | $634k | 189k | 3.35 |
|
|
| Fulcrum Therapeutics (FULC) | 0.0 | $161k | 14k | 11.31 |
|
|
| Repligen Corporation (RGEN) | 0.0 | $63k | 383.00 | 163.86 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2025 Q4 filed Feb. 13, 2026
- Alphabet 2025 Q3 filed Nov. 7, 2025
- Alphabet 2025 Q2 filed Aug. 1, 2025
- Alphabet 2025 Q1 filed May 2, 2025
- Alphabet 2024 Q4 filed Feb. 7, 2025
- Alphabet 2024 Q3 filed Nov. 8, 2024
- Alphabet 2024 Q2 filed Aug. 2, 2024
- Alphabet 2024 Q1 filed May 3, 2024
- Alphabet 2023 Q4 filed Feb. 9, 2024
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022
- Alphabet 2013 Q4 filed Nov. 15, 2022
- Alphabet 2014 Q1 filed Nov. 15, 2022